Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

DOXYCYCLINE MONO 100 MG CAP

DOXYCYCLINE
$0.2304per EA

Strength

100 mg/1

Manufacturer

Lupin Pharmaceuticals Inc.

NDC

68180065208

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DOXYCYCLINE

Approval Type

Generic (ANDA)

FDA Application

ANDA204234

On Market Since

2/20/2015

Pharmacological Classes

Tetracycline-class Drug
Tetracyclines

Price History

1W

0.0%

1M

-0.6%

3M

-1.1%

6M

-2.8%

1Y

-6.4%

3Y

-5.6%

5Y

-14.2%

All

-48.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

DOXYCYCLINE HYCLATE 20 MG TAB
Generic
42806036201•Epic Pharma LLC
$0.0937
per EA
DOXYCYCLINE HYCLATE 20 MG TAB
Generic
53489064701•Sun Pharmaceutical Industries Inc.
$0.0937
per EA
DOXYCYCLINE HYCLATE 20 MG TAB
Generic
62135062390•Chartwell RX LLC
$0.0937
per EA
DOXYCYCLINE HYCLATE 20 MG TAB
Generic
62332035231•Alembic Pharmaceuticals Inc.
$0.0937
per EA
DOXYCYCLINE HYCLATE 20 MG TAB
Generic
68047071401•Larken Laboratories, Inc.
$0.0937
per EA
DOXYCYCLINE HYCLATE 20 MG TAB
Generic
68047071460•Larken Laboratories, Inc.
$0.0937
per EA
DOXYCYCLINE HYCLATE 100 MG CAP
Generic
00143980305•Hikma Pharmaceuticals USA Inc.
$0.1152
per EA
DOXYCYCLINE HYCLATE 100 MG CAP
Generic
00143980350•Hikma Pharmaceuticals USA Inc.
$0.1152
per EA
DOXYCYCLINE HYCLATE 100 MG CAP
Generic
00904042804•Major Pharmaceuticals
$0.1152
per EA
DOXYCYCLINE HYCLATE 100 MG CAP
Generic
00904042806•Major Pharmaceuticals
$0.1152
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy